MYOK - MyoKardia - Don't Give Yourself Heartburn
MyoKardia (MYOK) is a clinical-stage biopharma company pioneering a precision medicine approach for the treatment of serious cardiovascular diseases. Precision medicine involves discovering and developing therapies that integrate clinical and molecular information based on the biological basis of disease. The company's strategy is to identify homogenous subgroups of patients with a given cardiovascular disease, understand the causal factors underlying that subgroup's condition, and develop targeted therapies designed to correct the common underlying defect leading to abnormal cardiac contraction or relaxation ("cardiomyopathies") within each subgroup. Specifically targeting certain muscle proteins ("myosin") could mitigate the